ReShape Lifesciences, Inc. (HIND) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ReShape Lifesciences, Inc. (HIND:NASDAQ), powered by AI.
- Current Price
- $2.20
- Sector
- Healthcare
What is the ReShape Lifesciences, Inc. stock price forecast?
ReShape Lifesciences, Inc. is currently trading at $2.20. View real-time AI analysis on Alpha Lenz.
What is ReShape Lifesciences, Inc. insider trading activity?
View the latest insider trading data for ReShape Lifesciences, Inc. on Alpha Lenz.
What is ReShape Lifesciences, Inc.'s P/E ratio?
View ReShape Lifesciences, Inc.'s valuation metrics on Alpha Lenz.
ReShape Lifesciences, Inc.
NASDAQ · HIND“ReShape Lifesciences, Inc.'s ROE is 1053.1%. Explore profitability and growth together.”
Ask for details →Company Overview
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“ReShape Lifesciences, Inc.'s ROE is 1053.1%. Explore profitability and growth together.”
Ask for details →Frequently Asked Questions
ReShape Lifesciences, Inc. (ticker: HIND) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 17 employees.
The current price is $2.2 with a P/E ratio of -x and P/B of -x.
ROE is 1053.07% and operating margin is -859.22%. Annual revenue is $319,714.